A phase 1 feasibility trial of BE-CAR33, an "off-the-shelf" base-edited CAR33 T cell therapy for acute myeloid leukemia. (science.org)

Authors: Georgiadis C … Qasim W Journal: Science Translational Medicine Published: 2026-08-19 DOI: https://doi.org/10.1126/scitranslmed.aei0875